Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Selchen

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|June 9, 2025
First-Line Use of Higher-Efficacy Disease-Modifying Therapies in Multiple Sclerosis: Canadian Consensus RecommendationsMark S Freedman, Fraser Clift, Virginia Devonshire, et al.
Multiple Sclerosis and Related Disorders|January 14, 2022
Clinical characteristics and outcomes of multiple sclerosis patients with COVID-19 in Toronto, CanadaJacqueline M Solomon, Ashley Jones, Marika Hohol, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|May 22, 2024
Health Canada Drug Approval Process: A Barrier to Personalized Care in Multiple SclerosisJiwon Oh, Virender Bhan, Anthony Traboulsee, et al.
AJNR. American Journal of Neuroradiology|June 26, 2024
Low-Field (64 mT) Portable MRI for Rapid Point-of-Care Diagnosis of Dissemination in Space in Patients Presenting with Optic NeuritisTimothy Reynold Lim, Suradech Suthiphosuwan, Jonathan Micieli, et al.
Multiple Sclerosis and Related Disorders|December 24, 2022
Expert opinion on the long-term use of cladribine tablets for multiple sclerosis: Systematic literature review of real-world evidenceCelia Oreja-Guevara, Wallace Brownlee, Elisabeth G Celius, et al.
Cerebral Circulation - Cognition and Behavior|March 13, 2023
Language discordance as a marker of disparities in cerebrovascular risk and stroke outcomes: A multi-center Canadian studyRyan T Muir, Arunima Kapoor, Megan L Cayley, et al.
Lancet (London, England)|February 15, 2025
Efficacy and safety of intravenous nerinetide initiated by paramedics in the field for acute cerebral ischaemia within 3 h of symptom onset (FRONTIER): a phase 2, multicentre, randomised, double-blind, placebo-controlled studyJim Christenson, Michael D Hill, Richard H Swartz, et al.
The New England Journal of Medicine|June 26, 2014
Atrial fibrillation in patients with cryptogenic strokeDavid J Gladstone, Melanie Spring, Paul Dorian, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|November 8, 2014
Good is not Good Enough: The Benchmark Stroke Door-to-Needle Time Should be 30 MinutesNoreen Kamal, Oscar Benavente, Karl Boyle, et al.
Stroke|August 29, 2015
Rapid Assessment and Treatment of Transient Ischemic Attacks and Minor Stroke in Canadian Emergency Departments: Time for a Paradigm ShiftNoreen Kamal, Michael D Hill, Dylan P V Blacquiere, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|June 9, 2025
First-Line Use of Higher-Efficacy Disease-Modifying Therapies in Multiple Sclerosis: Canadian Consensus RecommendationsMark S Freedman, Fraser Clift, Virginia Devonshire, et al.
Multiple Sclerosis and Related Disorders|January 14, 2022
Clinical characteristics and outcomes of multiple sclerosis patients with COVID-19 in Toronto, CanadaJacqueline M Solomon, Ashley Jones, Marika Hohol, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|May 22, 2024
Health Canada Drug Approval Process: A Barrier to Personalized Care in Multiple SclerosisJiwon Oh, Virender Bhan, Anthony Traboulsee, et al.
AJNR. American Journal of Neuroradiology|June 26, 2024
Low-Field (64 mT) Portable MRI for Rapid Point-of-Care Diagnosis of Dissemination in Space in Patients Presenting with Optic NeuritisTimothy Reynold Lim, Suradech Suthiphosuwan, Jonathan Micieli, et al.
Multiple Sclerosis and Related Disorders|December 24, 2022
Expert opinion on the long-term use of cladribine tablets for multiple sclerosis: Systematic literature review of real-world evidenceCelia Oreja-Guevara, Wallace Brownlee, Elisabeth G Celius, et al.
Cerebral Circulation - Cognition and Behavior|March 13, 2023
Language discordance as a marker of disparities in cerebrovascular risk and stroke outcomes: A multi-center Canadian studyRyan T Muir, Arunima Kapoor, Megan L Cayley, et al.
Lancet (London, England)|February 15, 2025
Efficacy and safety of intravenous nerinetide initiated by paramedics in the field for acute cerebral ischaemia within 3 h of symptom onset (FRONTIER): a phase 2, multicentre, randomised, double-blind, placebo-controlled studyJim Christenson, Michael D Hill, Richard H Swartz, et al.
The New England Journal of Medicine|June 26, 2014
Atrial fibrillation in patients with cryptogenic strokeDavid J Gladstone, Melanie Spring, Paul Dorian, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|November 8, 2014
Good is not Good Enough: The Benchmark Stroke Door-to-Needle Time Should be 30 MinutesNoreen Kamal, Oscar Benavente, Karl Boyle, et al.
Stroke|August 29, 2015
Rapid Assessment and Treatment of Transient Ischemic Attacks and Minor Stroke in Canadian Emergency Departments: Time for a Paradigm ShiftNoreen Kamal, Michael D Hill, Dylan P V Blacquiere, et al.
Pageof 4